AGAshley N. Guillory

Ashley N. Guillory

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ashley N. Guillory has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • David N. Herndon

    Shriners Hospitals for Children, Galveston, Texas

    3 shared publications
  • Celeste C. Finnerty

    Department of Surgery, Division of Surgical Sciences, University of Texas Medical Branch, Galveston, TX

    2 shared publications
  • Charles D. Voigt

    From the Department of Surgery (K.D.C., G.F., R.P.C., M.S., C.D.V., G.H., J.C-D., C.P., A.G., D.N.H.), Institute for Translational Sciences (R.P.C., C.D.V., G.H., C.P., A.G., D.N.H.), University of Texas Medical Branch; and Shriners Hospital for Children (K.D.C., G.F., R.P.C., C.D.V., G.H., J.C-D., C.P., A.G., D.N.H.), Galveston, Texas

    2 shared publications
  • Craig Porter

    Arkansas Children’s Nutrition Center

    2 shared publications
  • Gabriel Hundeshagen

    Department of Surgery, University of Texas Medical Branch and Shriners Hospitals for Children, Galveston, TX USA; Department of Hand, Plastic and Reconstructive Surgery, Burn Center, BG Trauma Center Ludwigshafen, Department of Plastic Surgery, University of Heidelberg, Ludwigshafen, Germany

    2 shared publications
  • Janos Cambiaso-Daniel

    From the Department of Surgery (K.D.C., G.F., R.P.C., M.S., C.D.V., G.H., J.C-D., C.P., A.G., D.N.H.), Institute for Translational Sciences (R.P.C., C.D.V., G.H., C.P., A.G., D.N.H.), University of Texas Medical Branch; and Shriners Hospital for Children (K.D.C., G.F., R.P.C., C.D.V., G.H., J.C-D., C.P., A.G., D.N.H.), Galveston, Texas

    2 shared publications

Latest Publications

  • The renaissance man of burn surgery: Basil A. Pruitt, Jr.

    by Karel D. Capek, Guillermo Foncerrada, R. Patrick Clayton, Michaela Sljivich, Charles D. Voigt, Gabriel Hundeshagen, Janos Cambiaso-Daniel, Craig Porter, Ashley Guillory, David N. Herndon

    Dr. Basil A. Pruitt Jr., a consummate clinical and translational surgeon-scientist, has spent over half a century at the forefront of an advancing standard of burn care. Commanding the US Army Institute for Surgical Research in San Antonio, he trained generations of leading burn clinicians and allied scientists. At his direction, there were forged discoveries in resuscitation from shock, treatment of inhalation injury, control of burn-related infections, prevention of iatrogenic complications, and understanding the sympathetic, endocrine, and immune responses to burn injury. Most consequentially, this team was among the first to recognize and define alterations in the basal metabolic rate and thermoregulation consequent to burn injury. These investigations prompted groundbreaking insights into the coordinated nervous, autonomic, endocrine, immune, and metabolic outflows that a severely burned patient uses to remain alive and restore homeostasis. Marking his scientific consequence, many of his reports continue to bear fruit when viewed through a contemporary lens. This article summarizes some of the major findings of his career thus far and is intended to complement a Festschrift recently held in his honor.


  • The P50 Research Center in Perioperative Sciences

    by Celeste C. Finnerty, Karel D. Capek, Charles Voigt, Gabriel Hundeshagen, Janos Cambiaso-Daniel, Craig Porter, Linda E. Sousse, Amina El Ayadi, Ramon Zapata-Sirvent, Ashley N. Guillory, et al.

    Since the inception of the P50 Research Center in Injury and Peri-operative Sciences (RCIPS) funding mechanism, the National Institute of General Medical Sciences has supported a team approach to science. Many advances in critical care, particularly burns, have been driven by RCIPS teams. In fact, burns that were fatal in the early 1970s, prior to the inception of the P50 RCIPS program, are now routinely survived as a result of the P50-funded research. The advances in clinical care that led to the reduction in postburn death were made by optimizing resuscitation, incorporating early excision and grafting, bolstering acute care including support for inhalation injury, modulating the hypermetabolic response, augmenting the immune response, incorporating aerobic exercise, and developing antiscarring strategies. The work of the Burn RCIPS programs advanced our understanding of the pathophysiologic response to burn injury. As a result, the effects of a large burn on all organ systems have been studied, leading to the discovery of persistent dysfunction, elucidation of the underlying molecular mechanisms, and identification of potential therapeutic targets. Survival and subsequent patient satisfaction with quality of life have increased. In this review article, we describe the contributions of the Galveston P50 RCIPS that have changed postburn care and have considerably reduced postburn mortality.


  • Open Access

    Cardiovascular Dysfunction Following Burn Injury: What We Have Learned from Rat and Mouse Models

    by Ashley N. Guillory, Robert P. Clayton, David N. Herndon, Celeste C. Finnerty

    Severe burn profoundly affects organs both proximal and distal to the actual burn site. Cardiovascular dysfunction is a well-documented phenomenon that increases morbidity and mortality following a massive thermal trauma. Beginning immediately post-burn, during the ebb phase, cardiac function is severely depressed. By 48 h post-injury, cardiac function rebounds and the post-burn myocardium becomes tachycardic and hyperinflammatory. While current clinical trials are investigating a variety of drugs targeted at reducing aspects of the post-burn hypermetabolic response such as heart rate and cardiac work, there is still a paucity of knowledge regarding the underlying mechanisms that induce cardiac dysfunction in the severely burned. There are many animal models of burn injury, from rodents, to sheep or swine, but the majority of burn related cardiovascular investigations have occurred in rat and mouse models. This literature review consolidates the data supporting the prevalent role that β-adrenergic receptors play in mediating post-burn cardiac dysfunction and the idea that pharmacological modulation of this receptor family is a viable therapeutic target for resolving burn-induced cardiac deficits.